400 related articles for article (PubMed ID: 23439638)
1. OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.
Higgins PG; Pérez-Llarena FJ; Zander E; Fernández A; Bou G; Seifert H
Antimicrob Agents Chemother; 2013 May; 57(5):2121-6. PubMed ID: 23439638
[TBL] [Abstract][Full Text] [Related]
2. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
Amudhan SM; Sekar U; Arunagiri K; Sekar B
Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
[TBL] [Abstract][Full Text] [Related]
3. OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.
Poirel L; Marqué S; Héritier C; Segonds C; Chabanon G; Nordmann P
Antimicrob Agents Chemother; 2005 Jan; 49(1):202-8. PubMed ID: 15616297
[TBL] [Abstract][Full Text] [Related]
4. OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.
Higgins PG; Poirel L; Lehmann M; Nordmann P; Seifert H
Antimicrob Agents Chemother; 2009 Dec; 53(12):5035-8. PubMed ID: 19770279
[TBL] [Abstract][Full Text] [Related]
5. Loop-mediated isothermal amplification: Rapid and sensitive detection of the antibiotic resistance gene ISAba1-blaOXA-51-like in Acinetobacter baumannii.
Mu X; Nakano R; Nakano A; Ubagai T; Kikuchi-Ueda T; Tansho-Nagakawa S; Kikuchi H; Kamoshida G; Endo S; Yano H; Ono Y
J Microbiol Methods; 2016 Feb; 121():36-40. PubMed ID: 26707336
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii.
Raible KM; Sen B; Law N; Bias TE; Emery CL; Ehrlich GD; Joshi SG
Ann Clin Microbiol Antimicrob; 2017 Nov; 16(1):75. PubMed ID: 29145853
[TBL] [Abstract][Full Text] [Related]
7. Analysis of
Słoczyńska A; Wand ME; Tyski S; Laudy AE
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801221
[No Abstract] [Full Text] [Related]
8. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.
Zander E; Chmielarczyk A; Heczko P; Seifert H; Higgins PG
J Antimicrob Chemother; 2013 Feb; 68(2):308-11. PubMed ID: 23014718
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt.
Al-Agamy MH; Khalaf NG; Tawfick MM; Shibl AM; El Kholy A
Int J Infect Dis; 2014 May; 22():49-54. PubMed ID: 24607428
[TBL] [Abstract][Full Text] [Related]
10. ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
Agoba EE; Govinden U; Peer AKC; Osei Sekyere J; Essack SY
Microb Drug Resist; 2018 Nov; 24(9):1289-1295. PubMed ID: 29653481
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran.
Sohrabi N; Farajnia S; Akhi MT; Nahaei MR; Naghili B; Peymani A; Amiri Z; Rezaee MA; Saeedi N
Microb Drug Resist; 2012 Aug; 18(4):385-9. PubMed ID: 22352411
[TBL] [Abstract][Full Text] [Related]
12. Dissemination of OXA-23-producing and carbapenem-resistant Acinetobacter baumannii in a University Hospital in Tunisia.
Mansour W; Poirel L; Bettaieb D; Bouallegue O; Boujaafar N; Nordmann P
Microb Drug Resist; 2008 Dec; 14(4):289-92. PubMed ID: 19018672
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive and contemporary "snapshot" of β-lactamases in carbapenem resistant Acinetobacter baumannii.
Hujer AM; Hujer KM; Leonard DA; Powers RA; Wallar BJ; Mack AR; Taracila MA; Rather PN; Higgins PG; Prati F; Caselli E; Marshall SH; Clarke T; Greco C; Venepally P; Brinkac L; Kreiswirth BN; Fouts DE; Bonomo RA;
Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115242. PubMed ID: 33248392
[TBL] [Abstract][Full Text] [Related]
14. Emergence of Carbapenem-Hydrolyzing Oxacillinases in Acinetobacter baumannii in Children from Croatia.
Lukić-Grlić A; Kos M; Žižek M; Luxner J; Grisold A; Zarfel G; Bedenić B
Chemotherapy; 2019; 64(4):167-172. PubMed ID: 31707391
[TBL] [Abstract][Full Text] [Related]
15. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii.
Héritier C; Poirel L; Lambert T; Nordmann P
Antimicrob Agents Chemother; 2005 Aug; 49(8):3198-202. PubMed ID: 16048925
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.
Chen TL; Wu RC; Shaio MF; Fung CP; Cho WL
Antimicrob Agents Chemother; 2008 Jul; 52(7):2573-80. PubMed ID: 18443121
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007.
Pfeifer Y; Wilharm G; Zander E; Wichelhaus TA; Göttig S; Hunfeld KP; Seifert H; Witte W; Higgins PG
J Antimicrob Chemother; 2011 Sep; 66(9):1998-2001. PubMed ID: 21693460
[TBL] [Abstract][Full Text] [Related]
18. Characterization of blaOXA-143 variants in Acinetobacter baumannii and Acinetobacter pittii.
Zander E; Bonnin RA; Seifert H; Higgins PG
Antimicrob Agents Chemother; 2014 May; 58(5):2704-8. PubMed ID: 24566181
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Poirel L; Nordmann P
Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
[TBL] [Abstract][Full Text] [Related]
20. Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
Ku WW; Kung CH; Lee CH; Tseng CP; Wu PF; Kuo SC; Chen TL; Lee YT; Wang FD; Fung CP
J Microbiol Immunol Infect; 2015 Feb; 48(1):57-64. PubMed ID: 24064289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
